Fisher & Paykel Healthcare’s share price has dropped 4.5% in trading despite reporting growth was nearly back to normal after three financial years of impact from the Covid-19 pandemic.
The company’s full-year results for the 2023 financial year ending March 31 were in line with analysts’
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
